Probiotics are living microorganisms, or dietary components containing living microbes, that have a favourable effect on the host's health when utilised in sufficient amounts. The premise that probiotic microbes are alive is shared by both definitions. Furthermore, probiotics' efficacy and safety should be scientifically established. These microbes get their food from saliva and gingival crevicular fluid, allowing oral ecosystems to thrive. The microbiome in the oral cavity is heavily influenced by the host's overall health and dietary habits. The oral microenvironment is influenced by a wide variety of pH, nutrient availability, shedding and non-shedding surfaces, salivary and crevicular fluids, and other factors. Oral diseases are a critical public health issue, given the scope of the problem. They result in significant loss of productivity due to pain, impairment of function, and decreased quality of life, in addition to a financial burden on the host. Probiotics are gaining popularity as a preventative measure in dental care. Probiotic bacteria have been linked to a growing range of health advantages in recent decades, including the improvement of adaptive immune response.
Title : Probiotics in the prevention and treatment of atherosclerotic cardiovascular disease: Focus on molecular mechanisms
Dipak P Ramji, Cardiff University, United Kingdom
Title : Phytochemical analysis and antioxidant activity of Physalis minima
Suriyavathana Muthukrishnan, Periyar University, India
Title : Effect of dietary probiotic on the pH and colour characteristics of carcasses, breast fillets and drumsticks of broilers
Nurinisa Esenbuga, Ataturk University, Turkey
Title : Scale up for manufacturing next generation probiotics: Process development strategies and processes to fast track products into the market
Jason Ryan, Sacco System, Australia
Title : Saccharomyces Cerevisiae BT-1: A versatile probiotic with potential applications in gastrointestinal health
Pamela Jha, NMIMS, India
Title : Comprehensive evaluation of probiotics in topical applications through standardized in-vitro methodologies
Rachana B Urs, Cymbiotics Biopharma Private Limited, India